Diminished alpha2-plasmin inhibitor activity associated with the use of imatinib mesylate in patients with Philadelphia chromosome-positive haematologic cancerKeitaro Matsuo, Kosei Matsue, Kanichi Iwama et al.|Thrombosis and Haemostasis|2009Cited by 0